(VIANEWS) – The NASDAQ opens in less than five hours and Amicus Therapeutics‘s pre-market value is already 5.09% up.
The last session, NASDAQ finished with Amicus Therapeutics (FOLD) dropping 6.68% to $6.29. NASDAQ fell 3.18% to $11,364.24, following the last session’s downward trend on what was a very bearish trend trading session.
Volume
Today’s last reported volume for Amicus Therapeutics is 6644455, 83.04% above its average volume of 3629880.
Amicus Therapeutics’s last close was $6.29, 50.2% below its 52-week high of $12.63.
Amicus Therapeutics’s Sales
Amicus Therapeutics’s sales growth is 20.1% for the current quarter and 34.5% for the next. The company’s growth estimates for the present quarter and the next is 44.4% and 56%, respectively.
Volatility
Amicus Therapeutics’s last day, last week, and last month’s current intraday variation average was 7.15%, 5.74%, and 3.73%, respectively.
Amicus Therapeutics’s highest amplitude of average volatility was 9.95% (day), 11.64% (last week), and 7.14% (last month), respectively.
More news about Amicus Therapeutics (FOLD).
